MediWound (MDWD) Net Cash Flow (QoQ) (2013 - 2025)
MediWound (MDWD) Net Cash Flow (QoQ) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | MediWound | 170.65 Mn | 139.65 Mn | 337,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -188.42% |
| Sep 30, 2025 | 10,585.10% |
| Jun 30, 2025 | 96.14% |
| Mar 31, 2025 | -391.82% |
| Dec 31, 2024 | 0.41% |
| Sep 30, 2024 | 402.72% |
| Jun 30, 2024 | 87.58% |
| Mar 31, 2024 | -421.00% |
| Dec 31, 2023 | 122.53% |
| Sep 30, 2023 | 69.10% |
| Jun 30, 2023 | -281.73% |
| Mar 31, 2023 | 2,228.27% |
| Dec 31, 2022 | 116.43% |
| Sep 30, 2022 | 47.02% |
| Jun 30, 2022 | -247.28% |
| Mar 31, 2022 | 331.49% |
| Dec 31, 2021 | 10.29% |
| Sep 30, 2021 | -137.61% |
| Jun 30, 2021 | -112.07% |
| Mar 31, 2021 | 53.66% |